BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 3927536)

  • 1. Cyclosporine-induced nephrotoxicity in patients with autoimmune uveitis.
    Palestine AG; Austin HA; Nussenblatt RB
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):209-14. PubMed ID: 3927536
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal function in patients with autoimmune diseases treated with cyclosporine.
    von Graffenried B; Harrison WB
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):215-31. PubMed ID: 3839609
    [No Abstract]   [Full Text] [Related]  

  • 3. Nephrotoxicity of cyclosporine in autoimmune diseases.
    Hannedouche TP; Delgado AG; Gnionsahe AD; Boitard C; Noël LH; Grünfeld JP
    Adv Nephrol Necker Hosp; 1990; 19():169-85. PubMed ID: 2105578
    [No Abstract]   [Full Text] [Related]  

  • 4. Nephrotoxicity and hypertension in patients with autoimmune disease treated with cyclosporine.
    Dieterle A; Abeywickrama K; von Graffenried B
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):349-55. PubMed ID: 3381297
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapy for human autoimmune uveitis with low-dose cyclosporine plus bromocriptine.
    Palestine AG; Nussenblatt RB; Gelato M
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):131-5. PubMed ID: 3381268
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
    Chapman JR; Morris PJ
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclosporine nephrotoxicity: exploration of the risk factors and prognosis of the renal injury.
    Keown PA; Stiller CR; Wallace AC; McKenzie FN; Wall W
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):247-53. PubMed ID: 3895663
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal histopathologic alterations in patients treated with cyclosporine for uveitis.
    Palestine AG; Austin HA; Balow JE; Antonovych TT; Sabnis SG; Preuss HG; Nussenblatt RB
    N Engl J Med; 1986 May; 314(20):1293-8. PubMed ID: 3702930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional consequences and risk factors of chronic cyclosporine nephrotoxicity in type I diabetes trials.
    Feutren G
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):356-66. PubMed ID: 3381298
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal function and blood pressure in patients treated with cyclosporin A for uveitis.
    Deray G; Le Hoang P; Cacoub P; Aupetit B; Mertani A; Martinez F; Rottembourg J
    Eur J Clin Pharmacol; 1988; 34(6):601-4. PubMed ID: 3169111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine in the treatment of birdshot retinochoroidopathy.
    Le Hoang P; Girard B; Deray G; Le Minh H; De Kozak Y; Thillaye B; Faure JP; Rousselie F
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):128-30. PubMed ID: 3381267
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cyclosporin treatment in uveitis].
    Quentin CD; Vogel M
    Klin Monbl Augenheilkd; 1986 Mar; 188(3):248-50. PubMed ID: 3713099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective serial renal function studies in patients with nonrenal disease treated with cyclosporine A.
    Tegzess AM; Doorenbos BM; Minderhoud JM; Donker AJ
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):390-3. PubMed ID: 3363645
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal function and blood pressure in patients receiving long-term, low-dose cyclosporine therapy for idiopathic autoimmune uveitis.
    Deray G; Benhmida M; Le Hoang P; Maksud P; Aupetit B; Baumelou A; Jacobs C
    Ann Intern Med; 1992 Oct; 117(7):578-83. PubMed ID: 1524331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal interstitial fibrosis and vascular changes. Occurrence in patients with autoimmune diseases treated with cyclosporine.
    Svenson K; Bohman SO; Hällgren R
    Arch Intern Med; 1986 Oct; 146(10):2007-10. PubMed ID: 3767545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Side effects of systemic cyclosporine in patients not undergoing transplantation.
    Palestine AG; Nussenblatt RB; Chan CC
    Am J Med; 1984 Oct; 77(4):652-6. PubMed ID: 6486141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effects of cyclosporine G and D treatment on experimental autoimmune uveoretinitis and kidney in rats].
    Kawashima H; Okumura A; Fujino Y; Tange T; Horiuchi D; Higashihara E; Mochizuki M
    Nippon Ganka Gakkai Zasshi; 1987 Oct; 91(10):940-50. PubMed ID: 3502061
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclosporine in autoimmune diseases.
    Bach JF
    Transplant Proc; 1989 Jun; 21(3 Suppl 1):97-113. PubMed ID: 2741212
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal outcome after ciclosporin-induced nephrotoxicity.
    Tostivint I; du Montcel ST; Jaudon MC; Mallet A; Le Hoang P; Bodaghi B; Deray G; Bagnis CI
    Nephrol Dial Transplant; 2007 Mar; 22(3):880-5. PubMed ID: 17127700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine: therapeutic effects in rheumatic diseases.
    Amor B; Dougados M
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):218-23. PubMed ID: 3289207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.